Expansion of chronic lesions is linked to disease progression in relapsing–remitting multiple sclerosis patients
Samuel Klistorner(The University of Sydney), Alexander Klistorner(Macquarie University), Stuart L. Graham(Australian Hearing), Michael Barnett(The University of Sydney), John Parratt(Royal North Shore Hospital), Yuyi You(Macquarie University), Joshua Barton, Con Yiannikas(Royal North Shore Hospital)
Cited by 53
Related Papers
Atypical inflammatory demyelinating syndromes of the CNS
|The Lancet Neurology|2016|159
Safety and efficacy of MD1003 (high-dose biotin) in patients with progressive multiple sclerosis (SPI2): a randomised, double-blind, placebo-controlled, phase 3 trial
|The Lancet Neurology|2020|104
Amyloid-beta and tau protein beyond Alzheimer’s disease
|Neural Regeneration Research|2023|98
Choroid plexus volume in multiple sclerosis predicts expansion of chronic lesions and brain atrophy
|Annals of Clinical and Translational Neurology|2022|89